The Rose Sheet
   Full-text available via subscription Subscription journal
   ISSN (Print) 1530-1222
   Published by Informa plc Homepage  [13 journals]
  • California’s Prop 65 List Grows With Addition Of Beta-Myrcene
    • Abstract: California’s Office of Environmental Health Hazard Assessment has added beta-myrcene, a fragrance component, to its Proposition 65 list of chemicals known to the state to cause cancer following an NTP report’s finding linking the substance to carcinogenic activity in rats and mice. A group of industry associations strongly opposed the listing.
      PubDate: Fri, 27 Mar 2015 11:40:00 -040
  • Complaints Allege Guthy-Renker’s WEN
           Conditioner Line Causes Hair Loss
    • Abstract: A suit filed March 17 alleges the products cause extreme and possibly permanent damage to hair, including hair loss, visible bald spots and severe breakage. In an earlier suit, the firm argued that a mandatory agreement requires customers to submit claims to binding individual arbitration rather than proceeding in court.
      PubDate: Fri, 27 Mar 2015 11:35:01 -040
  • Hamburg Departure Hinged On Filling FDA Leadership Roster
    • Abstract: Susan Mayne brings “new strength and focus to CFSAN” and medical countermeasures expert Luciana Borio moves to chief scientist role. Hamburg offers previews on leadership approaches of Stephen Ostroff and Robert Califf.
      PubDate: Fri, 27 Mar 2015 11:25:08 -040
  • CIR Panel Mulls Its Role In Assessing Environmental Effects
    • Abstract: In deciding whether to reopen a review of nonoxynols, the Cosmetic Ingredient Review Expert Panel discussed its approach to ingredients that may have environmental effects. The panel issued four final reports at the March 17 meeting.
      PubDate: Wed, 25 Mar 2015 19:30:04 -040
  • FDA Cautions Consumers On Cosmetics Carrying Drug Claims
    • Abstract: In a March 23 Consumer Update posted to its website, FDA suggests that some cosmetic products “go too far” with their promises and urges consumers to be skeptical when faced with cosmetics featuring drug claims.
      PubDate: Tue, 24 Mar 2015 19:35:01 -040
  • Sun Care In Brief
    • Abstract: Coppertone’s AccuSpray technology will now feature in Coppertone Kids, ultraGuard and Wet ‘n Clear ranges; Rite Aid’s new private-label Receutics Active Skin Repair line includes Advanced Sunscreen SPF 40. More sun-care news in brief.
      PubDate: Mon, 23 Mar 2015 00:00:06 -040
  • BASF Asks FDA To Weigh Whole Sunscreen TEAs, Not Isolated Parts
    • Abstract: Chemical supplier’s representatives maintain a “weight-of-evidence” approach comprising repeated dose toxicity, photo-genotoxicity, dermal carcinogenicity and photo-carcinogenicity studies is adequate to establish safety for its bemotrizinol UV filter. FDA officials heard BASF’s position in a public meeting required by the Sunscreen Innovation Act.
      PubDate: Fri, 20 Mar 2015 10:30:01 -040
  • PCPC Science Chief Urges Industry To Embrace Ingredient Diversity
    • Abstract: In an interview with “The Rose Sheet,” Beth Lange, the Personal Care Products Council’s Chief Scientist, highlighted issues impacting manufacturers, suppliers and retailers that were discussed at the trade association’s Annual Meeting.
      PubDate: Thu, 19 Mar 2015 18:10:00 -040
  • Aligning U.S. With EU Cosmetic Definition Could Enable Claims, Reduce FDA
    • Abstract: Under the European Cosmetics Regulation, cosmetics by definition can “protect” parts of the body and “keep them in good condition,” which provides latitude for structure/function claims that firms do not have in the U.S. While there is interest, particularly among multinationals, for similar license in the states, the tradeoff could be more burdensome requirements for efficacy and safety substantiation that smaller companies could not support.
      PubDate: Thu, 19 Mar 2015 17:40:03 -040
  • Industry, FDA Discuss Making CIR Program ‘More Robust’
    • Abstract: As the cosmetics industry works to instill confidence in product safety and the mechanisms in place to vet ingredients, the Personal Care Products Council recently met with FDA to talk about refining the Cosmetic Ingredient Review program. The trade group wants to establish CIR panel findings as a first-line resource for FDA, particularly if legislation advances that would direct the agency to evaluate cosmetic ingredients for safety.
      PubDate: Thu, 19 Mar 2015 17:35:18 -040
  • Analysts Speculate On P&G Beauty Bundle Up For Possible Sale, IPO
    • Abstract: P&G could divest, at one fell swoop, prestige fragrances, makeup brands Cover Girl and Max Factor, and salon and small retail hair-care brands, analysts speculate, following reports that the firm is exploring a possible sale or IPO of beauty brands en masse.
      PubDate: Thu, 19 Mar 2015 17:35:11 -040
  • P&G’s NIOXIN Shows How To Address Hair
           Loss Without An FDA Warning
    • Abstract: With FDA scrutinizing the marketplace for cosmetics promoted as drugs, and a clear cautionary statement from the agency about topical products marketed as hair growers or hair-loss preventers, beauty firms have little choice but to incorporate approved OTC drug ingredients in such products. P&G’s professional hair-care brand NIOXIN has done just that with its new Advanced Thinning range featuring minoxidil.
      PubDate: Thu, 19 Mar 2015 17:35:02 -040
  • Regulatory Roulette: Playing In Today’s Skin-Care Market A Gamble
    • Abstract: Recent FDA warning letters to skin-care firms raise questions about the regulatory risks companies must assume to compete effectively in today’s marketplace. Former FDAer and EAS Senior Adviser John Bailey discusses the strategic decision before personal-care companies as they develop their marketing and the potential consequences of using structure/function claims.
      PubDate: Tue, 17 Mar 2015 16:35:01 -040
  • Cosmetic Animal Testing In Brief
    • Abstract: New legislation in Korea is expected to ban cosmetic animal testing beginning in 2017; As more countries around the world move toward similar bans, animal-welfare groups are setting their sights on the U.S. Meanwhile, PETA claims the European Chemicals Agency has shown “shocking ambivalence and reluctance” to adapt its REACH dossier evaluation approach to ensure animal tests are being conducted only as a “last resort.”
      PubDate: Fri, 13 Mar 2015 12:35:01 -040
  • Funding Freeze In Forecast For Next FDA Commissioner
    • Abstract: Commissioner Margaret Hamburg receives a warm farewell at a March 5 appropriations hearing, but the House subcommittee chair says fiscal 2016 funding likely will be flat. Hamburg’s pitch – that globalization has required a massive shift in agency thinking and reach – failed to move subcommittee members.
      PubDate: Fri, 13 Mar 2015 12:10:08 -040
  • In Brief: Hydroquinone-Free Brightening; L’Oreal In Ivory Coast;
           Revlon FY 2014 Results
    • Abstract: Products addressing hyperpigmentation accounted for nearly 25% of total product sales in the professional channel in 2014, with hydroquinone-free options “among the most dynamic performers,” Kline says. More news in brief.
      PubDate: Fri, 13 Mar 2015 12:10:01 -040
  • Brace For Impact: Lawsuit Challenges Prop 65 Safe Harbor For Lead
    • Abstract: Environmental nonprofit contends there is no safe exposure level for lead in a lawsuit challenging the Prop 65 safe harbor for the substance, which has enabled many cosmetics firms to forgo warning labeling in California to date. Attorneys and regulatory experts discuss the suit’s potential large-scale impact while identifying diethanolamine as potentially the cosmetics industry’s next major headache under Prop 65.
      PubDate: Thu, 12 Mar 2015 17:35:02 -040
  • New Products In Brief
    • Abstract: Athena Cosmetics parlays its BioPeptin Complex, featured in the firm’s RevitaLash Advanced Eyelash Conditioner, into new hair volume enhancement products; Remarkable Retinal Eye Cream and Refining Sugar Cleanser debut from Mychelle Dermaceuticals. More product launch news.
      PubDate: Thu, 12 Mar 2015 17:30:00 -040
  • Cosmetic Adverse Event Reports Spiked 56% In Fiscal 2014 – FDA
    • Abstract: According to FDA’s Office of Cosmetics and Colors, the number of cosmetic adverse events reported to the agency reached 491 in fiscal 2014, a 56% increase over fiscal 2013. FDA reps say the agency’s data can be deceptive and the total number likely would be higher if cosmetic adverse-event reporting were mandatory.
      PubDate: Thu, 12 Mar 2015 17:15:01 -040
  • Weekly Trademark Review Feb 17, 2015
    • Abstract: Class 3 (Cosmetics and Cleaning Preps) compiled by “The Rose Sheet” from Official Gazette of the U.S. Patent and Trademark Office Product Name Trademark No./ Serial No. Company Filed Date Published Class Nos.
      PubDate: Thu, 12 Mar 2015 12:00:02 -040
  • Will Cosmeceutical Pioneer Turn Its Wagons Around' FDA Warns
    • Abstract: FDA cites Strivectin’s Potent Wrinkle Reducing Treatment and TL Advanced Tightening Neck Cream as unapproved drugs based on claims touting elastin-stimulating effects, skin-firming action and other structure/function benefits. Widely credited as a pioneer that helped create the cosmeceutical category, Strivectin has been warning-free since 2005 when FDA came down on its “Better than Botox?” positioning.
      PubDate: Wed, 11 Mar 2015 16:20:01 -040
  • Feinstein Bill To Mandate Fragrance Ingredient Contacts, Not Disclosure
    • Abstract: Cosmetics legislation poised for introduction in the Senate is likely to uphold the trade-secret status of fragrance compositions, promoting “a direct communication line” between FDA and fragrance houses rather than requiring full disclosure of fragrance ingredients, according to IFRA North America.
      PubDate: Tue, 10 Mar 2015 16:45:01 -040
  • Regulatory News In Brief: House Microbeads Bill; Oregon Eyes
           Children’s Cosmetics; More
    • Abstract: Rep. Frank Pallone, D-N.J., reintroduces his bill proposing a ban on personal-care products containing synthetic plastic microbeads; Oregon legislation would require ingredient reporting and reformulations from manufacturers of children’s cosmetics containing flagged chemicals.
      PubDate: Mon, 09 Mar 2015 00:00:33 -040
  • In Brief: NPD On Cosmetic Shoppers; African Beauty Market; Avon’s FY
    • Abstract: The NPD Group reports a 4% decline in U.S. beauty shoppers in 2014; Avon releases its fiscal 2014 results, while Energizer announces its personal-care spinoff will be called Edgewell Personal Care. More news in brief.
      PubDate: Mon, 09 Mar 2015 00:00:24 -040
  • FDA Remains Focused On Cosmetics Carrying Drug Claims – OCAC
    • Abstract: At the American Conference Institute’s Legal, Regulatory and Compliance Forum on Cosmetics, FDA Office of Cosmetics and Colors Director Linda Katz discussed her division’s priorities for the year. On the enforcement front, OCAC will continue to focus on cosmetic products marketed with drug claims, she said.
      PubDate: Thu, 05 Mar 2015 18:35:01 -050
School of Mathematical and Computer Sciences
Heriot-Watt University
Edinburgh, EH14 4AS, UK
Tel: +00 44 (0)131 4513762
Fax: +00 44 (0)131 4513327
About JournalTOCs
News (blog, publications)
JournalTOCs on Twitter   JournalTOCs on Facebook

JournalTOCs © 2009-2015